Brief: Incyte And Genesis Expand Molecular Ai Collaboration To Accelerate Drug Discovery

Incyte

20/05/2026 13:45

May 20 (Reuters) - Incyte Corp INCY.O:

INCYTE AND GENESIS EXPAND MOLECULAR AI COLLABORATION TO ACCELERATE DRUG DISCOVERY

INCYTE - GENESIS TO RECEIVE $120 MILLION UPFRONT INCLUDING $80 MILLION CASH AND $40 MILLION EQUITY PURCHASE

INCYTE - TO PROVIDE RECURRING RESEARCH FUNDING TO GENESIS FOR AI MODEL TRAINING

INCYTE - GENESIS ELIGIBLE TO RECEIVE OVER $1 BILLION IF ALL MILESTONES ACHIEVED ACROSS FIVE TARGETS

INCYTE - GENESIS ELIGIBLE TO RECEIVE ROYALTIES ON SALES OF APPROVED COLLABORATION PRODUCTS

Source text: ID:nBwc8D86ta

Further company coverage: INCY.O

 ((Reuters.Briefs@thomsonreuters.com;))